Last checked at 
(Adds background, detail)
By Alistair Smout
LONDON, Dec 30 (Reuters) - Britain on Wednesday became the
first country in the world to approve a coronavirus vaccine
developed by Oxford University and AstraZeneca as it
battles a major winter surge driven by a new, highly contagious
variant of the virus.
"The government has today accepted the recommendation from
the Medicines and Healthcare products Regulatory Agency (MHRA)
to authorise Oxford University/AstraZeneca’s COVID-19 vaccine
for use," the health ministry said.
The pandemic has already killed 1.7 million people around
the world, sown chaos through the global economy and upended
normal life for billions since it began in Wuhan, China, a year
ago.
Britain and South Africa in particular are grappling with
new variants of the coronavirus, which the government and
scientists say are more contagious; many countries have
responded by banning passenger flights and blocking trade.
AstraZeneca and other developers have said they are studying
the impact of the new variant but expect that their shots will
be effective against it.
Regulatory endorsement is a welcome boost for AstraZeneca
and the Oxford team, which have been accused of a lack of
clarity about the results from late-stage trials.
(Reporting by Alistair Smout; editing by Guy Faulconbridge)
